Kim Kardashian is known for many accomplishments. But now she can add another to her resume: First author of a paper in the Drug Designing & Intellectual Properties International Journal. What can we say? It’s international, and it’s a journal. We talked to Tomáš Pluskal, a post-doc at MIT and the last author of the paper … Continue reading Kim Kardashian pairs up with an MIT post-doc to publish a scientific paper
This week at Retraction Watch featured a hotly debated guest post from Leonid Schneider and two ORI findings. Here’s what was happening elsewhere:
We reported last week on a Portuguese group that lost two papers over mislabeled image files. Now, we’ve learned that first author Christian Ramos has been fired after speaking to Retraction Watch and offering what seemed like a heartfelt apology (which you can read here).
The Journal of Neuroscience has retracted a 2011 paper by a group of UCLA researchers after the institution concluded that a post-doc at the institution had falsified data. The article, “Epigenetic Enhancement of BDNF Signaling Rescues Synaptic Plasticity in Aging,” came from the lab of Cui-Wei “Tracy” Xie, a behavioral scientist. It has been cited 42 … Continue reading UCLA probe ends in retraction for neuroscience post-doc
Shane Mayack, a former post-doc in Harvard lab of Amy Wagers, a rising star in the stem cell field, has been sanctioned by the Office of Research Integrity for misconduct. Mayack, who has defended her actions on this blog as honest error — albeit sloppiness — and has not admitted to wrongdoing, must undergo supervision … Continue reading ORI finds Harvard stem cell lab post-doc Mayack manipulated images
The Journal of Materials Science: Materials in Medicine has retracted a 2011 paper after it was determined that the first author, then a post-doc at the University of Michigan, had plagiarized from another publication. The first author of the retracted article, “Functionalization of titanium based metallic biomaterials for implant applications,” was the post-doc, Rahul Bhola, … Continue reading Materials paper retracted after post-doc’s plagiarism
More on the case of Savio Woo, the New York gene therapy researcher who, as Retraction Watch reported this week, had several papers pulled by noted journals. Two of Woo’s post-doctoral fellows at Mount Sinai School of Medicine were dismissed for “research misconduct,” said Ian Michaels, a spokesman for the institution. According to Michaels: When … Continue reading Update on gene therapy researcher Savio Woo retractions: Two post-docs dismissed for fraud
Same tea, different mug. Biomolecules, an MDPI journal, has retracted a 2018 paper by on the salubrious effects of tea because the authors had previously published the same article in a Chinese-language journal. The paper, “Evaluation of anti-obesity activity, acute toxicity, and subacute toxicity of probiotic dark tea,” came from researchers in China and one … Continue reading When a paper duplicates one in another language, how can editors spot it?
A former researcher at Cedars-Sinai Medical Center has been sanctioned by a Federal watchdog for misconduct in a 2017 paper that claimed to link food preservatives and obesity. Uthra Rajamani, first author of the paper in Nature Communications, “engaged in research misconduct,” according to the U.S. Office of Research Integrity (ORI), and agreed to have … Continue reading Former Cedars-Sinai scientist committed misconduct in food preservatives-obesity paper
Last month, a judge recommended that a former University of Kansas Medical Center professor be banned from Federal U.S. funding for two years. The ban came after an investigation showed that the researcher, Rakesh Srivastava, had submitted a grant application that was heavily plagiarized from someone else’s. But there’s far more to the case, as … Continue reading A colleague included plagiarized material in your grant proposal. Are you liable?